glutathione dichloromethane dehalogenase EAWAG-BBD: reaction, reacID# r0188 Novel Mechanism for Dehalogenation and

(2000) Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism

Branched-chain amino acid levels, typically reduced in cirrhosis patients, were restored through supplementation, which alleviated muscle cramps, particularly with higher and nocturnal doses, yielding minimal self-limiting adverse events

Des troubles digestifs, de type nause, constipation ou diarrhe, une fatigue importante ainsi quune faiblesse musculaire peuvent galement tre observs

Additionally, the non-competitive NMDA antagonist memantine has been utilized in clinical trials of ASD